MIMOSA Diagnostics Inc

Company profile

About MIMOSA Diagnostics Inc

MIMOSA Diagnostics Inc. is a medical technology company that has developed MIMOSA Pro, a handheld multispectral imaging device that enables non-invasive assessment of tissue health. The company's core innovation transforms traditionally large, 12-foot-tall near-infrared spectroscopy machines into a portable, palm-sized device that clinicians can use at the bedside or in remote care settings. MIMOSA Pro uses near-infrared (NIR) and infrared light to measure tissue oxygen saturation and temperature beneath the skin surface, providing real-time insights into tissue perfusion and health status that are not visible to the naked eye. The technology serves multiple clinical applications including wound care management, post-operative monitoring, peripheral vascular disease assessment, burn depth evaluation, and pediatric cardiac surgery monitoring. The device is particularly valuable for assessing diabetic foot ulcers, monitoring surgical flaps, and triaging patients at risk of tissue complications. MIMOSA Pro integrates with a secure cloud-based web portal that enables remote consultation between specialists and point-of-care clinicians, facilitating communication and longitudinal tracking of patient physiology. The company's mission centers on reshaping equity in healthcare by bringing expert-level tissue assessment capabilities to diverse care settings including hospitals, group practices, home care, and emergency field situations. By standardizing tissue health assessment regardless of clinician training level, MIMOSA Diagnostics aims to enable earlier diagnosis of vascular complications and reduce catastrophic outcomes such as amputations.

Company description · MIMOSA Diagnostics Inc official website